Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 347-353, 2018.
Artículo en Inglés | WPRIM | ID: wpr-812396

RESUMEN

Gnaphalium affine D. Don, a medicinal and edible plant, has been used to treat gout in traditional Chinese medicine and popularly consumed in China for a long time. A detailed phytochemical investigation on the aerial part of G. affine led to the isolation of two new esters of caffeoylquinic acid named (-) ethyl 1, 4-di-O-caffeoylquinate (1) and (-) methyl 1, 4-di-O-caffeoylquinate (2), together with 35 known compounds (3-37). Their structures were elucidated by spectroscopic data and first-order multiplet analysis. All the isolated compounds were tested for their xanthine oxidase inhibitory activity with an in vitro enzyme inhibitory screening assay. Among the tested compounds, 1 (IC 11.94 μmol·L) and 2 (IC 15.04 μmol·L) showed a good inhibitory activity. The current results supported the medical use of the plant.


Asunto(s)
Adenina , Química , Medicamentos Herbarios Chinos , Química , Farmacología , Activación Enzimática , Flavonoides , Química , Gnaphalium , Química , Supresores de la Gota , Química , Farmacología , Hidroxibenzoatos , Química , Estructura Molecular , Resonancia Magnética Nuclear Biomolecular , Fitoquímicos , Química , Farmacología , Componentes Aéreos de las Plantas , Química , Extractos Vegetales , Química , Farmacología , Ácido Quínico , Química , Xantina Oxidasa
2.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 347-353, 2018.
Artículo en Inglés | WPRIM | ID: wpr-773607

RESUMEN

Gnaphalium affine D. Don, a medicinal and edible plant, has been used to treat gout in traditional Chinese medicine and popularly consumed in China for a long time. A detailed phytochemical investigation on the aerial part of G. affine led to the isolation of two new esters of caffeoylquinic acid named (-) ethyl 1, 4-di-O-caffeoylquinate (1) and (-) methyl 1, 4-di-O-caffeoylquinate (2), together with 35 known compounds (3-37). Their structures were elucidated by spectroscopic data and first-order multiplet analysis. All the isolated compounds were tested for their xanthine oxidase inhibitory activity with an in vitro enzyme inhibitory screening assay. Among the tested compounds, 1 (IC 11.94 μmol·L) and 2 (IC 15.04 μmol·L) showed a good inhibitory activity. The current results supported the medical use of the plant.


Asunto(s)
Adenina , Química , Medicamentos Herbarios Chinos , Química , Farmacología , Activación Enzimática , Flavonoides , Química , Gnaphalium , Química , Supresores de la Gota , Química , Farmacología , Hidroxibenzoatos , Química , Estructura Molecular , Resonancia Magnética Nuclear Biomolecular , Fitoquímicos , Química , Farmacología , Componentes Aéreos de las Plantas , Química , Extractos Vegetales , Química , Farmacología , Ácido Quínico , Química , Xantina Oxidasa
3.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 527-533, 2016.
Artículo en Inglés | WPRIM | ID: wpr-812594

RESUMEN

The aim of the study was to investigate the anti-proliferation and apoptosis-inducing effects of S1, a novel tetrandrine derivative, in human gastric cancer BGC-823 cells and explore the possible mechanism of action. The anti-proliferative activity was determined by MTT assay; the induction of cell cycle arrest and apoptosis were detected by flow cytometry. Quantitative real time RT-PCR and Western blotting were used to evaluate the mRNA and protein expression levels in mitochondrial pathway. S1 significantly reduced cell viability and induced a G2/M phase arrest and apoptosis in dose- and time-dependent manner. Further studies showed that S1 increased mRNA and protein expression of Bax and the Bax/Bcl-2 ratio. Moreover, S1 decreased the protein expression of procaspase-9 and procaspase-3, suggesting that the induction of apoptosis may be related to the alteration of the ratio of Bax/Bcl-2 and the activation of caspases. These findings suggested that S1 merits further investigation as a novel therapeutic agent for the treatment of human gastric cancer.


Asunto(s)
Humanos , Antineoplásicos , Farmacología , Apoptosis , Bencilisoquinolinas , Química , Farmacología , Caspasa 3 , Genética , Metabolismo , Caspasa 9 , Genética , Metabolismo , Puntos de Control del Ciclo Celular , Línea Celular Tumoral , Proliferación Celular , Supervivencia Celular , Proteínas Proto-Oncogénicas c-bcl-2 , Genética , Metabolismo , Neoplasias Gástricas , Quimioterapia , Genética , Proteína X Asociada a bcl-2 , Genética , Metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA